Steris Plc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Steris Plc in the fourth quarter 2026?
Steris Plc achieved a return on average equity (ROE) of 11.29 % in its fourth quarter 2026, this is above STE's average return on equity of 9.01%.
Steris Plcs equity during the 12 months ending in the fourth quarter 2026 are valued at $6 billion

ROE has advanced compared to 10.44% in the third quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry 33 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2026 from 1235 to 1264.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Mar 31 2026) IV. Quarter	(Dec 31 2025) III. Quarter	(Sep 30 2025) II. Quarter	(Jun 30 2025) I. Quarter	(Mar 31 2025) IV. Quarter
Y / Y Equity Change	8.79 %	4.76 %	6.23 %	9.41 %	-
Y / Y Net Income Change	50.81 %	12.13 %	27.34 %	22.3 %	-
Net Income (TTM) in Millions	785	711	690	649	616
Return On Equity (TTM)	11.29 %	10.44 %	10.25 %	9.78 %	9.51 %
STE's Total Ranking	# 1264	# 1235	# 1245	# 1198	# 1082
Equity (TTM) in Millions	7,197	6,616	7,023	6,970	6,616
Seq. Equity Change	8.79 %	-5.79 %	0.75 %	5.35 %	4.76 %
Seq. Net Income Change	13.38 %	0.94 %	8.15 %	21.86 %	-15.7 %

Back to STE Management Effectiveness >> STE's 5 Years Annual ROE >> Compare STE ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 34
Sector	# 130
Overall	# 1264

Return On Equity Statistics
High	Average	Low
17.86 %	9.01 %	-1.7 %
(Mar 31 2013)		(Sep 30 2022)

STE Annual Return On Equity	(Mar 31 2026) 2026	(Mar 31 2025) 2025	(Mar 31 2024) 2024	(Mar 31 2023) 2023	(Mar 31 2018) 2018
Total Equity in Millions	7,197	6,616	6,315	6,087	3,217
Y / Y Equity Change	8.79 %	4.76 %	3.75 %	89.2 %	14.49 %
Net Income in Millions	785	616	380	106	292
Y / Y Net Income Change	27.44 %	62.09 %	259.2 %	-63.72 %	163.6 %
Return On Equity	10.91 %	9.31 %	6.02 %	1.74 %	9.06 %

Back to STE Management Effectiveness >> STE's 5 Years Annual ROE >> Compare STE ROE to its Competitors

Annual Roe Comment

In 2026 ROE improved to 10.91 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
STE's' Return on Equity at Yahoo Finance
STE's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for STE's Competitors
Subscribers only: Roe for Steris Plc's Suppliers
Subscribers only: Return On Equity for STE's Customers

Companies with similar Return On Equity at Mar 31 2026, within Healthcare Sector	ROE
Solventum Corporation	30.71 %
Phibro Animal Health Corporation	30.60 %
Pro dex Inc	30.01 %
Incyte Corporation	29.20 %
Protalix Biotherapeutics inc	28.10 %
Collegium Pharmaceutical Inc	26.74 %
Pacs Group Inc	26.46 %
Johnson and Johnson	26.26 %
Engene Therapeutics Inc	25.83 %
Encompass Health Corporation	25.56 %
Chemed Corporation	25.33 %
Resmed Inc	24.76 %
Iradimed Corporation	24.48 %
Lantheus Holdings Inc	24.33 %
Prestige Consumer Healthcare Inc	24.20 %
Vertex Pharmaceuticals Inc	23.93 %
Catalyst Pharmaceuticals Inc	23.65 %
Xoma Royalty Corporation	23.64 %
Soleno Therapeutics Inc	22.85 %
Electromed Inc	22.41 %
Iqvia Holdings Inc	22.15 %
Msa Safety Inc	22.03 %
Neurocrine Biosciences Inc	21.64 %
Insulet Corporation	21.38 %
Universal Health Services Inc	21.22 %
Teva Pharmaceutical Industries Limited	20.74 %
Exagen Inc	20.63 %
Sotera Health Company	20.57 %
Puma Biotechnology Inc	20.37 %
Pediatrix Medical Group Inc	20.09 %

Date modified: 2026-08-14T21:16:43+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.